Background: Sunitinib malate is a novel oral multitargeted tyrosine kinase inhibitor with antitumor and
antiangiogenic activities. Only mass spectrometry detection is currently available to determine sunitinib in
human plasma. The purpose of this study was to develop a simple and sensitive high-performance liquid
chromatographic method with UV-Visible detection for quantification of sunitinib concentrations in human
plasma